Zhou H, Coffin CM, Perkins SL, Tripp SR, Liew M, Viskochil DH
Tirzepatide is a dual-agonist , meaning it works by targeting two hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Retatrutide is a triple-agonist , meaning it targets three hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Glucagon: affects energy use and fat metabolism Early studies show that retatrutide may be more successful than tirzepatide at managing diabetic kidney disease, as well as for weight control, while tirzepatide may be better at managing blood glucose
Prommer chose to publish his full protocol openly rather than use the medication quietly
Most people experience only a mild pinch or slight stinging sensation lasting a few seconds
Las personas que tienen un IMC de ms de 30 tienen una indicacin de tratamiento farmacolgico, adems de las pautas higinico-dietticas (alimentacin y actividad fsica)
Archambault, A
